Role of IL-17A, IL-17F, and the IL-17 Receptor in Regulating Growth-Related Oncogene-α and Granulocyte Colony-Stimulating Factor in Bronchial Epithelium: Implications for Airway Inflammation in Cystic Fibrosis 1
暂无分享,去创建一个
J. Kolls | J. Pilewski | F. McAllister | B. Carreno | J. Finder | J. Pirhonen | P. J. Dubin | C. Steele | S. Goldman | J. Kreindler | Adam C. Henry | L. Ulrich
[1] K. Adler,et al. A biphasic chamber system for maintaining polarity of differentiation of culture respiratory tract epithelial cells , 1988, In Vitro Cellular & Developmental Biology.
[2] V. Wahn,et al. Cytokines in neutrophil-dominated airway inflammation in patients with cystic fibrosis , 1995, European Archives of Oto-Rhino-Laryngology.
[3] S. Gaffen,et al. Cytokines link osteoblasts and inflammation: microarray analysis of interleukin‐17‐ and TNF‐α‐induced genes in bone cells , 2005, Journal of leukocyte biology.
[4] M. Goldman,et al. IL‐23 up‐regulates IL‐10 and induces IL‐17 synthesis by polyclonally activated naive T cells in human , 2005, European journal of immunology.
[5] R. de Waal Malefyt,et al. IL‐12 and IL‐23: master regulators of innate and adaptive immunity , 2004, Immunological reviews.
[6] A. Lindén,et al. Interleukin-17 family members and inflammation. , 2004, Immunity.
[7] Hidetada Sasaki,et al. Regulatory roles of IL-17 and IL-17F in G-CSF production by lung microvascular endothelial cells stimulated with IL-1β and/or TNF-α , 2004 .
[8] J. Uddin,et al. Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway , 2004, Nature Immunology.
[9] J. Shellito,et al. Cutting Edge: Roles of Toll-Like Receptor 4 and IL-23 in IL-17 Expression in Response to Klebsiella pneumoniae Infection1 , 2003, The Journal of Immunology.
[10] E. Lubberts. The role of IL-17 and family members in the pathogenesis of arthritis. , 2003, Current opinion in investigational drugs.
[11] T. Moseley,et al. Interleukin-17 family and IL-17 receptors. , 2003, Cytokine & growth factor reviews.
[12] S. Ferretti,et al. IL-17, Produced by Lymphocytes and Neutrophils, Is Necessary for Lipopolysaccharide-Induced Airway Neutrophilia: IL-15 as a Possible Trigger , 2003, The Journal of Immunology.
[13] A. Gurney,et al. Interleukin-23 Promotes a Distinct CD4 T Cell Activation State Characterized by the Production of Interleukin-17* , 2003, The Journal of Biological Chemistry.
[14] A. Andoh,et al. Increased expression of interleukin 17 in inflammatory bowel disease , 2003, Gut.
[15] J. Kolls,et al. Interleukin-17: an emerging role in lung inflammation. , 2003, American journal of respiratory cell and molecular biology.
[16] P. Hellings,et al. Interleukin-17 orchestrates the granulocyte influx into airways after allergen inhalation in a mouse model of allergic asthma. , 2003, American journal of respiratory cell and molecular biology.
[17] A. Lindén,et al. Neutrophilic airway inflammation and IL‐17 , 2002, Allergy.
[18] M. Konstan,et al. The role of inflammation in the pathophysiology of CF lung disease , 2002, Clinical reviews in allergy & immunology.
[19] R. Hromas,et al. Cutting Edge: IL-17D, a Novel Member of the IL-17 Family, Stimulates Cytokine Production and Inhibits Hemopoiesis1 , 2002, The Journal of Immunology.
[20] R. Coffman,et al. New IL-17 Family Members Promote Th1 or Th2 Responses in the Lung: In Vivo Function of the Novel Cytokine IL-251 , 2002, The Journal of Immunology.
[21] Katie Chan,et al. Interleukin-17 stimulates the expression of interleukin-8, growth-related oncogene-alpha, and granulocyte-colony-stimulating factor by human airway epithelial cells. , 2002, American journal of respiratory cell and molecular biology.
[22] Jorge R. Oksenberg,et al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis , 2002, Nature Medicine.
[23] M. Konstan,et al. Prolonged inflammatory response to acute Pseudomonas challenge in interleukin-10 knockout mice. , 2002, American journal of respiratory and critical care medicine.
[24] A. Gurney,et al. IL‐17: prototype member of an emerging cytokine family , 2002, Journal of leukocyte biology.
[25] M. Konstan,et al. Murine models of CF airway infection and inflammation. , 2002, Methods in molecular medicine.
[26] F. Accurso,et al. Airway inflammation in children with cystic fibrosis and healthy children assessed by sputum induction. , 2001, American journal of respiratory and critical care medicine.
[27] G. Sledge,et al. Cutting Edge: IL-17F, a Novel Cytokine Selectively Expressed in Activated T Cells and Monocytes, Regulates Angiogenesis and Endothelial Cell Cytokine Production1 , 2001, The Journal of Immunology.
[28] R. Kelley,et al. IL‐17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL‐17F, and implications for receptor binding , 2001, The EMBO journal.
[29] J. Shellito,et al. Requirement of Interleukin 17 Receptor Signaling for Lung Cxc Chemokine and Granulocyte Colony-Stimulating Factor Expression, Neutrophil Recruitment, and Host Defense , 2001, The Journal of experimental medicine.
[30] J. Shellito,et al. Interleukin-17 and lung host defense against Klebsiella pneumoniae infection. , 2001, American journal of respiratory cell and molecular biology.
[31] J. Pilewski,et al. Pharmacological modulation of ion transport across wild-type and DeltaF508 CFTR-expressing human bronchial epithelia. , 2000, American journal of physiology. Cell physiology.
[32] J. Kolls,et al. Requirement of Endogenous Stem Cell Factor and Granulocyte-Colony-Stimulating Factor for IL-17-Mediated Granulopoiesis1 , 2000, The Journal of Immunology.
[33] M. Laan,et al. Airway neutrophils and interleukin-17. , 2000, The European respiratory journal.
[34] A. Gurney,et al. Cloning and characterization of IL-17B and IL-17C, two new members of the IL-17 cytokine family. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[35] J. Lötvall,et al. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. , 1999, Journal of immunology.
[36] A. Miller,et al. IL-17 stimulates granulopoiesis in mice: use of an alternate, novel gene therapy-derived method for in vivo evaluation of cytokines. , 1998, Journal of immunology.
[37] W. Fanslow,et al. Human IL-17: a novel cytokine derived from T cells. , 1995, Journal of immunology.
[38] George Kollias,et al. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor , 1995, Cell.